Data gathered: May 17
Alternative Data for Catalyst Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Employee Rating | 79 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | 2 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 12 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,917 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 15,662 | Sign up | Sign up | Sign up |
| Twitter Followers | 873 | Sign up | Sign up | Sign up |
| Twitter Mentions | 22 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 40 | Sign up | Sign up | Sign up |
| Business Outlook | 100 | Sign up | Sign up | Sign up |
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for people with rare debilitating diseases, chronic neuromuscular and neurological diseases.
| Price | $16.40 |
| Target Price | Sign up |
| Volume | 1,330,000 |
| Market Cap | $1.97B |
| Year Range | $11.69 - $17.29 |
| Dividend Yield | 0% |
| PE Ratio | 29.75 |
| Revenue per Employee | $5,016,427 |
| Industry | Biotechnology |
In the news
Catalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms marketMay 14 - MarketWatch |
|
 |
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS RatingMay 14 - Biztoc.com |
 |
Russell Investments Group Ltd. Raises Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)May 13 - ETF Daily News |
 |
Catalyst Pharmaceuticals (NASDAQ:CPRX) Cut to “Hold” at StockNews.comMay 13 - ETF Daily News |
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call TranscriptMay 10 - Yahoo Entertainment |
|
Bank of America Securities Sticks to Their Buy Rating for Catalyst Pharma (CPRX)May 9 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 99M | 69M | 30M | 23M | 36M | 0.000 |
| Q4 '23 | 111M | 67M | 44M | 35M | 51M | 0.310 |
| Q3 '23 | 103M | 48M | 55M | -31M | -29M | -0.290 |
| Q2 '23 | 100M | 40M | 59M | 38M | 55M | 0.530 |
| Q1 '23 | 85M | 46M | 39M | 30M | 42M | 0.260 |
Insider Transactions View All
| Tierney David S filed to sell 348,874 shares at $15.7. April 10 '24 |
| Elsbernd Brian filed to sell 124,433 shares at $16.4. March 28 '24 |
| Tierney David S filed to sell 333,541 shares at $13.3. December 14 '23 |
Similar companies
Read more about Catalyst Pharmaceuticals (CPRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & business outlook.
What is the Market Cap of Catalyst Pharmaceuticals?
The Market Cap of Catalyst Pharmaceuticals is $1.97B.
What is Catalyst Pharmaceuticals' PE Ratio?
As of today, Catalyst Pharmaceuticals' PE (Price to Earnings) ratio is 29.75.
How Many People Work at Catalyst Pharmaceuticals?
As of our latest update, Catalyst Pharmaceuticals employed approximately 82 people worldwide. However, it's important to note that Catalyst Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Catalyst Pharmaceuticals' revenue per employee?
$5,016,427. To calculate Catalyst Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Catalyst Pharmaceuticals?
Currently, the price of one share of Catalyst Pharmaceuticals stock is $16.40.
How can I analyze the CPRX stock price chart for investment decisions?
The CPRX stock price chart above provides a comprehensive visual representation of Catalyst Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Catalyst Pharmaceuticals shares. Our platform offers an up-to-date CPRX stock price chart, along with technical data analysis and alternative data insights.
Does CPRX offer dividends to its shareholders?
As of our latest update, Catalyst Pharmaceuticals (CPRX) does not offer dividends to its shareholders. Investors interested in Catalyst Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Catalyst Pharmaceuticals?
Some of the similar stocks of Catalyst Pharmaceuticals are Amgen, Gilead Sciences, Inovio Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.
.